0001393905-18-000012.txt : 20180111 0001393905-18-000012.hdr.sgml : 20180111 20180111110646 ACCESSION NUMBER: 0001393905-18-000012 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180103 FILED AS OF DATE: 20180111 DATE AS OF CHANGE: 20180111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PORTAGE BIOTECH INC. CENTRAL INDEX KEY: 0001095435 STANDARD INDUSTRIAL CLASSIFICATION: CRUDE PETROLEUM & NATURAL GAS [1311] STATE OF INCORPORATION: A6 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 18523012 BUSINESS ADDRESS: STREET 1: 47 AVENUE ROAD STREET 2: SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5R 2G3 BUSINESS PHONE: 416-929-1806 MAIL ADDRESS: STREET 1: 47 AVENUE ROAD STREET 2: SUITE 200 CITY: TORONTO STATE: A6 ZIP: M5R 2G3 FORMER NAME: FORMER CONFORMED NAME: BONTAN CORP INC DATE OF NAME CHANGE: 20030421 FORMER NAME: FORMER CONFORMED NAME: DEALCHECK COM INC DATE OF NAME CHANGE: 19990921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 234 CHURCH STREET, SUITE 304 CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 234 CHURCH STREET, SUITE 304 CITY: NEW HAVEN STATE: CT ZIP: 06510 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0306 4/A 2018-01-03 2018-01-04 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001095435 PORTAGE BIOTECH INC. 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 ONTARIO, CANADA 0 0 1 0 Common Stock 2018-01-04 4 S 0 4350 28.6217 D 6301500 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.45 - $28.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Kam Shah, CFO 2018-01-10